Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Letendre

Showing results (181-190 of 247) with videos related to

Pageof 25
Sort By:
Viruses|January 23, 2024
Effects of Opioid Withdrawal on Psychobiology in People Living with HIVIgor Grant, Evgeny Krupitsky, Marina Vetrova, et al.
Molecular Neurobiology|July 1, 2021
Higher CSF Ferritin Heavy-Chain (Fth1) and Transferrin Predict Better Neurocognitive Performance in People with HIVHarpreet Kaur, William S Bush, Scott L Letendre, et al.
Journal of Neurovirology|June 8, 2023
Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depressionRong Fu, Hyder Jinnah, J Lucas Mckay, et al.
Journal of Neurovirology|December 20, 2012
Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infectionErica Weber, Erin E Morgan, Jennifer E Iudicello, et al.
Brain, Behavior, & Immunity - Health|September 30, 2021
Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIVRonald J Ellis, Scott L Letendre, J Hampton Atkinson, et al.
AIDS (London, England)|May 6, 2009
Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease coursePatrick R Harrington, Gretja Schnell, Scott L Letendre, et al.
AIDS (London, England)|February 6, 2025
Cerebrospinal fluid biomarkers of inflammation and immune activation associated with neurocognitive impairment among US Latinos with HIVMonica M Diaz, Lily Kamalyan, Tala Al-Rousan, et al.
Brain : a Journal of Neurology|December 8, 2022
Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER studyRobert K Heaton, Ronald J Ellis, Bin Tang, et al.
The Journal of Infectious Diseases|December 7, 2023
Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIVMattia Trunfio, Bin Tang, Jennifer E Iudicello, et al.
Journal of the International Neuropsychological Society : JINS|April 29, 2025
Independent and combined adverse effects of neurocognitive impairment and depression on everyday functioning and quality of life in people with HIVCrystal X Wang, Victoria O Chentsova, Maximo R Prescott, et al.
Pageof 25

Showing results (181-190 of 247) with videos related to

Sort By:
Pageof 25
Viruses|January 23, 2024
Effects of Opioid Withdrawal on Psychobiology in People Living with HIVIgor Grant, Evgeny Krupitsky, Marina Vetrova, et al.
Molecular Neurobiology|July 1, 2021
Higher CSF Ferritin Heavy-Chain (Fth1) and Transferrin Predict Better Neurocognitive Performance in People with HIVHarpreet Kaur, William S Bush, Scott L Letendre, et al.
Journal of Neurovirology|June 8, 2023
Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depressionRong Fu, Hyder Jinnah, J Lucas Mckay, et al.
Journal of Neurovirology|December 20, 2012
Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infectionErica Weber, Erin E Morgan, Jennifer E Iudicello, et al.
Brain, Behavior, & Immunity - Health|September 30, 2021
Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIVRonald J Ellis, Scott L Letendre, J Hampton Atkinson, et al.
AIDS (London, England)|May 6, 2009
Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease coursePatrick R Harrington, Gretja Schnell, Scott L Letendre, et al.
AIDS (London, England)|February 6, 2025
Cerebrospinal fluid biomarkers of inflammation and immune activation associated with neurocognitive impairment among US Latinos with HIVMonica M Diaz, Lily Kamalyan, Tala Al-Rousan, et al.
Brain : a Journal of Neurology|December 8, 2022
Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER studyRobert K Heaton, Ronald J Ellis, Bin Tang, et al.
The Journal of Infectious Diseases|December 7, 2023
Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIVMattia Trunfio, Bin Tang, Jennifer E Iudicello, et al.
Journal of the International Neuropsychological Society : JINS|April 29, 2025
Independent and combined adverse effects of neurocognitive impairment and depression on everyday functioning and quality of life in people with HIVCrystal X Wang, Victoria O Chentsova, Maximo R Prescott, et al.
Pageof 25